XML 30 R14.htm IDEA: XBRL DOCUMENT v3.26.3
HPI - Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Net income $ 164,200 $ 132,928
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 236,068 219,982
Amortization of lease incentives and acquisition-related intangible assets and liabilities 2,442 1,791
Share-based compensation expense 8,348 7,446
Net credit losses on operating lease receivables 2,019 (776)
Accrued interest on mortgages and notes receivable 1,898 (877)
Amortization of debt issuance costs 4,712 4,276
Amortization of cash flow hedges (155) (186)
Amortization of mortgages and notes payable fair value adjustments 259 84
Impairments of real estate assets 0 8,800
Losses on debt extinguishment 58 144
Net gains on disposition of property (109,569) (87,889)
Equity in earnings of unconsolidated affiliates (3,339) (2,223)
Distributions of earnings from unconsolidated affiliates 5,038 5,277
Changes in operating assets and liabilities:    
Accounts receivable (586) 621
Prepaid expenses and other assets (816) (1,102)
Accrued straight-line rents receivable (26,936) (9,510)
Accounts payable, accrued expenses and other liabilities (3,785) (19,263)
Net cash provided by operating activities 279,856 259,523
Investing activities:    
Investments in acquired real estate and related intangible assets, net of cash acquired (309,838) (248,017)
Investments in development in-process (8,882) (1,967)
Investments in tenant improvements and deferred leasing costs (132,494) (110,065)
Investments in building improvements (39,160) (30,760)
Net proceeds from disposition of real estate assets 380,269 153,586
Distributions of capital from unconsolidated affiliates 152,845 6,288
Investments in mortgages and notes receivable 0 (1,577)
Repayments of mortgages and notes receivable 0 6,350
Investments in and advances to unconsolidated affiliates (34,426) (21,576)
Changes in earnest money deposits 0 10,000
Changes in other investing activities (2,800) (1,616)
Net cash provided by/(used in) investing activities 5,514 (239,354)
Financing activities:    
Dividends on Common Stock (165,268) (161,778)
Redemptions/repurchases of Preferred Stock (60) (2,120)
Redemptions of Common Units (24) (10)
Dividends on Preferred Stock (1,722) (1,783)
Distributions to noncontrolling interests in the Operating Partnership (3,025) (3,227)
Distributions to noncontrolling interest in consolidated affiliates (9,589) (240)
Contributions from noncontrolling interests in consolidated affiliates 197,202 0
Proceeds from the issuance of Common Stock 934 51,819
Costs paid for the issuance of Common Stock (659) (1,204)
Repurchase of shares related to tax withholdings (1,865) (2,009)
Borrowings on revolving credit facility 203,000 390,000
Repayments of revolving credit facility (228,000) (274,000)
Borrowings on mortgages and notes payable 20,000 31,600
Repayments of mortgages and notes payable (39,279) (37,157)
Payments for debt issuance costs and other financing activities (1,379) (1,994)
Net cash used in financing activities (29,734) (12,103)
Net increase in cash and cash equivalents and restricted cash 255,636 8,066
Cash and cash equivalents and restricted cash at beginning of the period 43,049 33,677
Cash and cash equivalents and restricted cash at end of the period 298,685 41,743
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents at end of the period 279,205 26,262
Restricted cash at end of the period 19,480 15,481
Supplemental disclosure of cash flow information:    
Cash paid for interest, net of amounts capitalized 133,255 123,314
Supplemental disclosure of non-cash investing and financing activities:    
Unrealized losses on cash flow hedges 1,008 0
Conversions of Common Units to Common Stock 700 3,329
Changes in accrued capital expenditures [1] 29,289 (2,105)
Write-off of fully depreciated real estate assets 60,293 71,956
Write-off of fully amortized leasing costs 22,951 35,962
Write-off of fully amortized debt issuance costs 1,124 1,388
Adjustment of noncontrolling interests in the Operating Partnership to fair value 6,635 3,240
Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities $ 74,300 $ 50,800
[1] Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities as of September 30, 2026 and 2025 were $74.3 million and $50.8 million, respectively.